| Size | Price | Stock | Qty |
|---|---|---|---|
| 250mg |
|
||
| Other Sizes |
|
Purity: ≥98%
| ln Vivo |
Neuroprotective properties of intravenous (10 mg/kg) ammonium(VI) tetrathiomolybdate (ATTM) are noteworthy [1].
|
|---|---|
| Animal Protocol |
Animal/Disease Models: Wistar rat[1]
Doses: 10 mg/kg Route of Administration: intravenous (iv) (iv)injection Experimental Results: Functional activities were improved 24 hrs (hrs (hours)) and 7 days after reperfusion, while the infarct size was Dramatically diminished. |
| References | |
| Additional Infomation |
Tiomolibdate Diammonium is an ammonium salt with potential antiangiogenic and antitumor activities. Tetrathiomolybdate has been found to deplete systemic copper reserves through an unknown mechanism. This agent has been shown to inhibit the activities of cuproenzymes, including superoxide dismutase 1 (SOD1) and cytochrome c oxidase (COX), which may contribute to its antiangiogenic and antitumor effects.
|
| Molecular Formula |
H8MON2S4
|
|---|---|
| Molecular Weight |
260.278
|
| Exact Mass |
261.862
|
| CAS # |
15060-55-6
|
| Related CAS # |
Tetrathiomolybdate;16330-92-0
|
| PubChem CID |
15251598
|
| Appearance |
Brown to black solid powder
|
| Melting Point |
>300 °C(lit.)
|
| LogP |
2.044
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
7
|
| Complexity |
19.1
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
ZKKLPDLKUGTPME-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/Mo.2H3N.2H2S.2S/h;2*1H3;2*1H2;;
|
| Chemical Name |
diazanium;bis(sulfanylidene)molybdenum;sulfanide
|
| Synonyms |
Tiomolibdate diammonium Ammonium tetrathiomolybdate Ammonium molybdenum sulfide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~5 mg/mL (~19.21 mM)
H2O : < 0.1 mg/mL |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.5 mg/mL (1.92 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 0.5 mg/mL (1.92 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.8420 mL | 19.2101 mL | 38.4202 mL | |
| 5 mM | 0.7684 mL | 3.8420 mL | 7.6840 mL | |
| 10 mM | 0.3842 mL | 1.9210 mL | 3.8420 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA